The team found that the law dramatically reduced out-of-pocket costs, with an average annual savings of nearly $600 per patient.

New research shows that treatment of heart failure patients with a type of anti-obesity medication reduces the environmental footprint of healthcare, as well as improving clinical outcomes.  

People being treated for heart failure with GLP-1 receptor antagonists used 0.25 kg CO₂-equivalent less per person annually, compared to patients with heart failure taking a placebo. When this saving is scaled to the millions of people eligible for the treatment, the findings suggest that 2 billion kilograms of CO₂-equivalent could be saved annually. 

The study is one of the first to quantify the environmental co-benefits of pharmacologic treatment. The authors hope that studies like this will empower policy makers, clinicians and patients to consider environmental outcomes alongside clinical outcomes in the future. 

Collaborative organizations, involving government agencies, nonprofit groups and other key stakeholders, are often created to address regional challenges such as preserving watersheds – but these organizations often fail to accomplish their stated goals. A new study suggests there is a specific administrative approach that improves the ability of these collaborative groups to deliver the services they were created to provide.

About The Study: In this study, underrepresented in medicine (URiM) student matriculation into U.S. medical schools declined after the 2023 Supreme Court of the United States (SCOTUS) ruling, with an emergent disparity in acceptance rates of URiM applicants relative to Asian and white students. The decline in URiM student matriculation was concentrated in states without a preexisting state-level affirmative action ban, suggesting that there may be an association between the SCOTUS ruling and demographic changes in matriculation.

The International Society for Stem Cell Research (ISSCR) is proud to announce a collaboration with the Novo Nordisk Foundation to host the ISSCR Annual Meeting in Copenhagen, Denmark 27-30 June 2028.

The ISSCR Annual Meeting embodies the mission of both world-class organizations, supporting new frontiers in rigorous science to better human health. The conference is a revered global forum for stem cell science and regenerative medicine, uniting researchers, clinicians, industry leaders, and policy makers from more than 80 countries.